Taiwan Liposome Company Overview

Taiwan Liposome Company EBIT

EBIT (Earnings Before Interest and Taxes) analysis for TLC.

Quarterly EBIT

-$91.53M

↑ 64.33% YoY

As of Jun 30, 2021

Annual EBIT (TTM)

-$811.53M

↑ 11.5% YoY

Trailing 12 months ending Jun 30, 2021

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin